SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000914208-19-000306
Filing Date
2019-06-10
Accepted
2019-06-10 11:15:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 17460
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 5496
  Complete submission text file 0000914208-19-000306.txt   24988
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45385 | Film No.: 19887968
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309
Business Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

IRS No.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
Assistant Director 7